PanGen Biotech Inc. (KOSDAQ:222110)
South Korea
· Delayed Price · Currency is KRW 4,955.00
-20.00 (-0.40%)
At close: Mar 9, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 66.86 billion as of March 9, 2026. Its market cap has decreased by -0.31% in one year.
Market Cap
66.86B
Enterprise Value
54.55B
Revenue
15.27B
Ranking
n/a
PE Ratio
39.09
Stock Price
4,955.00
Market Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 66.86B, a decrease of -60.97%. That is a compound annual growth rate of -8.99%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ark Solutions | 68.91B |
| HLB Pep | 64.87B |
| SunBio,Inc. | 64.75B |
| CHA Vaccine Research Institute | 72.80B |
| Aptamer Sciences | 56.56B |
| EyeGene | 56.54B |
| Naturalendo Tech | 81.77B |
| Shaperon | 83.61B |